Unknown

Dataset Information

0

Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases.


ABSTRACT: BACKGROUND: Stereotactic Ablative RadioTherapy (SABR) of lung tumors/metastases has been shown to be an effective treatment modality with low toxicity. Outcome and toxicity were retrospectively evaluated in a unique single-institution cohort treated with intensity-modulated image-guided breath-hold SABR (igSABR) without external immobilization. The dose-response relationship is analyzed based on Biologically Equivalent Dose (BED). PATIENTS AND METHODS: 50 lesions in 43 patients with primary NSCLC (n = 27) or lung-metastases of various primaries (n = 16) were consecutively treated with igSABR with Active-Breathing-Coordinator (ABC®) and repeat-breath-hold cone-beam-CT. After an initial dose-finding/-escalation period, 5 x 12 Gy for peripheral lesions and single doses of 5 Gy to varying dose levels for central lesions were applied. Overall-survival (OS), progression-free-survival (PFS), progression pattern, local control (LC) and toxicity were analyzed. RESULTS: The median BED2 was 83 Gy. 12 lesions were treated with a BED2 of <80 Gy, and 38 lesions with a BED2 of >80 Gy. Median follow-up was 15 months. Actuarial 1- and 2-year OS were 67% and 43%; respectively. Cause of death was non-disease-related in 27%. Actuarial 1- and 2-year PFS was 42% and 28%. Progression site was predominantly distant. Actuarial 1- and 2 year LC was 90% and 85%. LC showed a trend for a correlation to BED2 (p = 0.1167). Pneumonitis requiring conservative treatment occurred in 23%. CONCLUSION: Intensity-modulated breath-hold igSABR results in high LC-rates and low toxicity in this unfavorable patient cohort with inoperable lung tumors or metastases. A BED2 of <80?Gy was associated with reduced local control.

SUBMITTER: Boda-Heggemann J 

PROVIDER: S-EPMC3909294 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature

altmetric image

Publications

Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases.

Boda-Heggemann Judit J   Frauenfeld Anian A   Weiss Christel C   Simeonova Anna A   Neumaier Christian C   Siebenlist Kerstin K   Attenberger Ulrike U   Heußel Claus Peter CP   Schneider Frank F   Wenz Frederik F   Lohr Frank F  

Radiation oncology (London, England) 20140108


<h4>Background</h4>Stereotactic Ablative RadioTherapy (SABR) of lung tumors/metastases has been shown to be an effective treatment modality with low toxicity. Outcome and toxicity were retrospectively evaluated in a unique single-institution cohort treated with intensity-modulated image-guided breath-hold SABR (igSABR) without external immobilization. The dose-response relationship is analyzed based on Biologically Equivalent Dose (BED).<h4>Patients and methods</h4>50 lesions in 43 patients with  ...[more]

Similar Datasets

| S-EPMC5497083 | biostudies-literature
| S-EPMC7033782 | biostudies-literature
| S-EPMC8299524 | biostudies-literature
| S-EPMC5871611 | biostudies-literature
| S-EPMC7707327 | biostudies-literature
| S-EPMC7328270 | biostudies-literature
| S-EPMC8159969 | biostudies-literature
| S-EPMC4078155 | biostudies-literature
| S-EPMC6823694 | biostudies-literature
| S-EPMC6620660 | biostudies-literature